CORE SCIENTIFIC INC

Weiss Eric Stanton buys 6,000 shares of Core Scientific, signaling steady insider confidence in the company’s AI‑driven infrastructure pivot and potential upside for investors.

Inside Core Scientific’s planned insider sales: Todd Duchene’s Rule 10b‑5‑1 strategy shows disciplined liquidity, not panic, while the company’s AI‑powered blockchain tech keeps upside potential high for long‑term investors.

Core Scientific’s insider buying signals AI‑and‑blockchain growth—IT leaders learn how to adopt micro‑services, observability, and serverless AI for cost‑efficient, future‑ready strategies.

Core Scientific insider trading: Todd Duchene sells 21,205 shares at $20.10, a routine plan move amid mixed price action and high social‑media buzz.

Inside the insider sales of Core Scientific: 8,300 shares sold for $200k+ amid a pivot to AI‑driven data‑center services, AMD partnership, and disciplined trading plans.

Core Scientific insider selling: Todd DuChene’s July 20, 2026 10K‑share sale highlights systematic trading amid market volatility. Understand the impact on stock confidence and future growth potential.

Core Scientific insider sale sparks market buzz—explore how CEO liquidity moves and blockchain‑AI tech impact investors & cyber security.

Core Scientific insider sales reveal investor sentiment, but expert analysis shows how microservices, AI observability and hybrid cloud can unlock biotech growth.

Insightful insider sale by Todd M. Duchene at Core Scientific: 10 000+ shares off the table amid a 20% monthly gain, yet the AI‑blockchain partnership keeps bullish prospects alive.

Core Scientific’s insider sale under Rule 10b‑5‑1 shows a disciplined liquidity plan, not panic, yet adds volatility risk—read how governance, investor trust, and crypto‑security align.